protocolSection identificationModule nctId: NCT06297148, orgStudyIdInfo id: 2023/590816, briefTitle: The HIP Self-management Study, acronym: HIPS, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-12, primaryCompletionDateStruct date: 2026-07-01, completionDateStruct date: 2027-01-01, studyFirstPostDateStruct date: 2024-03-07, lastUpdatePostDateStruct date: 2024-03-21, sponsorCollaboratorsModule leadSponsor name: Oslo University Hospital, class: OTHER, collaborators name: Oslo Metropolitan University, collaborators name: Fysiofondet, collaborators name: University of Oslo, descriptionModule briefSummary: The HIPS-study will be an observer blinded, single-centre, parallel-group randomized controlled trial (RCT).The main purpose of the study is:1. To investigate the clinical effectiveness of a self- management program versus usual care for patients with greater trochanteric pain syndrome (GTPS).   * H0: There is no difference between a self-management program and usual care on pain and function in patients with GTPS.   * H1: There is a difference between a self-management program and usual care on pain and function in patients with GTPS.2. To investigate if self-management is more cost-effective than usual care in the treatment of patients with GTPS.Participants will be randomly allocated into one of two groups: 1) self-management program or 2) usual care.Follow-up will be at 3-, 6- and 12-months., conditionsModule conditions: GTPS - Greater Trochanteric Pain Syndrome, conditions: Gluteal Tendinopathy, conditions: Trochanteric Bursitis, conditions: Lateral Hip Pain, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 110, type: ESTIMATED, armsInterventionsModule interventions name: Self-management, interventions name: Usual care, outcomesModule primaryOutcomes measure: Victorian Institute of Sport Assessment Gluteal Questionnaire (VISA-G), secondaryOutcomes measure: Numeric rating scale (NRS), secondaryOutcomes measure: Painful sites, secondaryOutcomes measure: The Pain Self-Efficacy Questionnaire (PSEQ), secondaryOutcomes measure: EuroQoL-5 dimensions-5 Level (Eq-5D-5L), secondaryOutcomes measure: Hopkins Symptoms checklist-10 (HSCL-10), secondaryOutcomes measure: iMTA Medical Consumption Questionnaire (iMCQ), secondaryOutcomes measure: iMTA Productivity Cost Questionnaire (iPCQ), secondaryOutcomes measure: Expectations related to VISA-G, secondaryOutcomes measure: Expectations on numeric rating scale (NRS), secondaryOutcomes measure: Global rating of change (GROC), eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 70 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Oslo University Hospital, Ullevål, status: RECRUITING, city: Oslo, zip: 0450, country: Norway, contacts name: Marianne Bakke Johnsen, PhD, role: CONTACT, phone: + 47 92439663, email: m.b.johnsen@medisin.uio.no, contacts name: Marianne Bakke Johnsen, PhD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 59.91273, lon: 10.74609, documentSection largeDocumentModule largeDocs typeAbbrev: SAP, hasProtocol: False, hasSap: True, hasIcf: False, label: Statistical Analysis Plan, date: 2024-02-22, uploadDate: 2024-03-07T09:23, filename: SAP_001.pdf, size: 1180746, hasResults: False